Showing results (611-620 of 785) with videos related to

Sort By:
Pageof 79
Journal of Crohn'S & Colitis|September 10, 2022
Opportunistic Infections in Patients with Inflammatory Bowel Disease Treated with Advanced Therapies: A Systematic Review and Meta-Analysis of Randomized Controlled TrialsPablo A Olivera, Juan S Lasa, Ignacio Zubiaurre, et al.
Digestive Diseases and Sciences|June 13, 2019
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory PouchitisJacob E Ollech, David T Rubin, Laura Glick, et al.
Crohn'S & Colitis 360|May 14, 2025
US and European Patient and Health Care Professional Perspectives on Fatigue in Ulcerative Colitis and Crohn's Disease: Results From the Communicating Needs and Features of Inflammatory Bowel Disease Experiences SurveyRemo Panaccione, Alison Potts Bleakman, Stefan Schreiber, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 29, 2020
Effectiveness of Ustekinumab Dose Escalation in Patients With Crohn's DiseaseJacob E Ollech, Inessa Normatov, Noam Peleg, et al.
The Lancet. Gastroenterology & Hepatology|January 16, 2026
Efficacy and safety of subcutaneous guselkumab induction therapy in participants with moderately to severely active ulcerative colitis (ASTRO): a double-blind, treat-through, randomised, placebo-controlled, phase 3 trialMillie Long, Jessica R Allegretti, Silvio Danese, et al.
Journal of Crohn'S & Colitis|October 14, 2017
Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance StudiesJulian Panés, Séverine Vermeire, James O Lindsay, et al.
Journal of Crohn'S & Colitis|April 1, 2025
Corticosteroid-sparing effects of risankizumab efficacy and safety in patients with moderately to severely active ulcerative colitisWalter Reinisch, Edward V Loftus, Stefan Schreiber, et al.
Alimentary Pharmacology & Therapeutics|December 27, 2019
Efficacy and safety of induction therapy with calcineurin inhibitors followed by vedolizumab maintenance in 71 patients with severe steroid-refractory ulcerative colitisJacob E Ollech, Sujaata Dwadasi, Victoria Rai, et al.
Alimentary Pharmacology & Therapeutics|May 9, 2020
Risk factors and treatment outcomes of peristomal pyoderma gangrenosum in patients with inflammatory bowel diseaseJingzhou Wang, Joshua Prenner, Wenfei Wang, et al.
Gastrointestinal Endoscopy|August 8, 2018
Utility of video capsule endoscopy for longitudinal monitoring of Crohn's disease activity in the small bowel: a prospective studyGil Y Melmed, Marla C Dubinsky, David T Rubin, et al.
Pageof 79